Skip to main content
. 2006 Jan 7;12(1):82–88. doi: 10.3748/wjg.v12.i1.82

Table 3.

Characteristics of the patients entering the randomized double-blind phase of the study

Lansoprazole (30 mg/d) (n = 17) Lansoprazole (60 mg/d) (n = 18)
Age (mean±SD) 57.5 ± 11.9 52.4±10.0
Gender, male (% ) 3 (17.6) 2 (11.1)
Upper endoscopy positive (%) 4 (23.5) 3 (16.7)
pH-metry positive (%) 13 (76.5) 10 (55.5)
PPI test positive (%) 11 (64.7) 11 (61.1)

No statistical differences between the groups in any of the parameters.